A new variant of the sigma-1 (1)receptor is useful in screening
compounds useful in the imaging and treatment of proliferative masses (i.e., tumors).
This new variant, named sigma—1 (1)
finds particular use in the non-invasive diagnosis of cancer and more particularly
in the diagnosis of proliferative cancer cells.
